Clin2
NCT07779343Likely a fitRecruiting

Multidisciplinary support for adults living with obesity

Obesity Difficult Airway Airway ManagementObesity Adult OnsetObesity and Cardiovascular RiskObesity Type 2 Diabetes Mellitus

Part of Hormones & metabolism clinical trials.

This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • Your body mass index (BMI) is 30 or higher
  • You are not pregnant at the start of the study
  • You have not had weight-loss surgery in the past
  • You have not taken weight-loss medication in the last 90 days
  • You are willing to attend regular follow-up visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06633783Not yet recruiting· Phase 3
Weekly shot for weight loss in adults with obesity

This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.

Xuancheng, Anhui
NCT07055607Enrolling by invitation
Real-world study of Wegovy for weight management

This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.

Barcelona
NCT06977438Not yet recruiting· Phase 4
Weight loss program for teens with obesity

This study tests a weight loss program that combines a weekly medicine injection with lifestyle coaching for teens with obesity. It aims to help teens achieve a healthier weight and improve overall wellness.

Minneapolis, Minnesota
NCT07430059Not yet recruiting· Phase 1
Study of a semaglutide implant for weight management

This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.

NCT07767175Recruiting· Phase 1
Weight loss study for adults with overweight or obesity

This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.

Lenexa, Kansas
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

Hear when a new Obesity Difficult Airway Airway Management trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.